NASDAQ:IMGN
Delisted
ImmunoGen Stock News
$31.23
+0 (+0%)
At Close: May 08, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen to Present Full Results from SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at Society of Gynecologic Oncology Annual Meeting
ImmunoGen Inc. (NASDAQ: IMGN) Stock Forecast: Potential To Pass $20.00 Within A Year
06:00pm, Wednesday, 09'th Mar 2022 Stocks Register
The trading price of ImmunoGen Inc. (NASDAQ:IMGN) floating higher at last check on Wednesday, March 09, closing at $5.66, 5.11% higher than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it has … ImmunoGen Inc. (NASDAQ: IMGN) Stock Forecast: Potential To Pass $20.00 Within A Year Read More »
ImmunoGen (IMGN) Q4 Earnings and Sales Outpace Estimates
03:20pm, Monday, 28'th Feb 2022 Zacks Investment Research
ImmunoGen (IMGN) reports a narrower-than-expected loss for fourth-quarter 2021. It also beats revenue estimates. Post the announcement, the share price rises.
ImmunoGen, Inc. (IMGN) FY 2021 Earnings Call Transcript
09:08am, Saturday, 26'th Feb 2022 AlphaStreet
ImmunoGen, Inc. (NASDAQ: IMGN) FY 2021 earnings call dated Feb. 25, 2022 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President and Chief Executive Officer Anna […] The post ImmunoGen, Inc. (IMGN) FY 2021 Earnings Call Transcript first appeared on AlphaStreet .
ImmunoGen: Going In The Right Direction For Ovarian Cancer Cure
07:55am, Saturday, 26'th Feb 2022 Seeking Alpha
ImmunoGen (IMGN) Q4 2021 Earnings Call Transcript
11:00pm, Friday, 25'th Feb 2022 The Motley Fool
IMGN earnings call for the period ending December 31, 2021.
ImmunoGen (IMGN) Q4 2021 Earnings Call Transcript
11:00pm, Friday, 25'th Feb 2022 The Motley Fool
IMGN earnings call for the period ending December 31, 2021.
ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q4 2021 Results - Earnings Call Transcript
09:20pm, Friday, 25'th Feb 2022 Seeking AlphaImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q4 2021 Results - Earnings Call Transcript
04:20pm, Friday, 25'th Feb 2022
ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q4 2021 Results - Earnings Call Transcript
ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates
12:45pm, Friday, 25'th Feb 2022 Zacks Investment Research
ImmunoGen (IMGN) delivered earnings and revenue surprises of 5.56% and 6.96%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ImmunoGen GAAP EPS of -$0.17 beats by $0.01, revenue of $28M beats by $2.07M
11:31am, Friday, 25'th Feb 2022 Seeking Alpha
ImmunoGen press release (IMGN): Q4 GAAP EPS of -$0.17 beats by $0.01.Revenue of $28M (-67.4% Y/Y) beats by $2.07M.For 2022, ImmunoGen expects:revenues between $75 million and…
ImmunoGen Reports Recent Progress and 2021 Financial Results
11:30am, Friday, 25'th Feb 2022 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Reports Recent Progress and 2021 Financial Results
ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates
09:14am, Friday, 25'th Feb 2022
ImmunoGen (IMGN) delivered earnings and revenue surprises of 5.56% and 6.96%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ImmunoGen Q4 2021 Earnings Preview
04:35pm, Thursday, 24'th Feb 2022 Seeking Alpha
ImmunoGen (NASDAQ:IMGN) is scheduled to announce Q4 earnings results on Friday, February 25th, before market open.The consensus EPS Estimate is -$0.18 (-212.5% Y/Y) and the…
ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference
09:30pm, Wednesday, 23'rd Feb 2022 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference
